Ipsen: Dysport positive results in spasticity should help boost US potential

NEUTRAL, Fair Value EUR29.5 (-10%)

News published on December Tuesday 17, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities